Senior Driving Simulation Training for Subjective Cognitive Decline and Mild Cognitive Impairment
NCT ID: NCT05380284
Last Updated: 2023-06-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2022-06-28
2023-05-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Tinkering Activities in Individuals With Subjective Cognitive Decline
NCT06110858
Efficacy of a Multicomponent Cognitive Intervention in Adults With Subjective Cognitive Decline and Mild Cognitive Impairments
NCT04023032
Driving Evaluation and Fitness for Persons With Cognitive Impairments
NCT04648735
Cognitive Rehabilitation During Transcranial Direct Current Stimulation
NCT03050385
Effects of Cognitive Strategy Training on Daily Function in People With Subjective Cognitive Decline
NCT04330404
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental Group
Senior Driving Simulation Training
Senior Driving Simulation Training
The experimental group (Senior Driving Simulation Training: 30-mins training session two times per week for 5 weeks, with a total of 10 sessions) .
Control Group
Waiting-list
Waiting list control
The control group is waiting list control. They will also receive the (Senior Driving Simulation Training) after all research is done.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Senior Driving Simulation Training
The experimental group (Senior Driving Simulation Training: 30-mins training session two times per week for 5 weeks, with a total of 10 sessions) .
Waiting list control
The control group is waiting list control. They will also receive the (Senior Driving Simulation Training) after all research is done.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mild cognitive impairment (AD-8 scale ≥ 2 points), and MMSE\> 24 points, can maintain personal daily activity function.
* Can communicate in Chinese or Taiwanese.
* At least 60 years of age.
* Those with a car driving license.
* No physical impairment.
* In addition to the above conditions, participants must be voluntary and signed informed consent.
Exclusion Criteria
* Significant mental illness or communication impairment.
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taipei Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Huie-Ling Chiu
Assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Huei-Ling Chiu
Role: PRINCIPAL_INVESTIGATOR
Taipei Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Taipei Medical University
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N202002083
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.